Across Medicare beneficiaries, primary care visit rates and access decreased from 2017 to 2023, and telemedicine accounted for a small proportion of visits.

High legume and soy consumption is associated with a lower risk for hypertension, according to a recent review and meta-analysis.

Endometriosis is associated with an increased risk for congenital anomalies, according to results of a recent study.

For the first time ever, the U.S. Food and Drug Administration (FDA) authorized the sale of fruit-flavored e-cigarettes (“vapes”) for adults 21 and over. Th ...

Children with rheumatic diseases frequently experience unmet social needs, with the highest rates reported by those with SLE or JDM.

The EULAR released a 2025 update to the 2018 recommendations for physical activity among individuals with IA or OA, with an emphasis on reducing sedentary behavior.

Many Americans still engage in risky sun behaviors driven by misinformation, social media, and persistent tanning myths.

Glucagon-like peptide-1 receptor agonists may be a potential novel treatment for alcohol use disorder, according to results of a recent study.

Use of IL-17 inhibitors is effective and safe for the treatment of PsO involving difficult-to-treat anatomical sites.

We summarized existing research on weight loss medications in rheumatic disease and their potential for improving quality of ...

Weight loss-focused lifestyle interventions significantly impacted bone health biomarkers among patients with T2D.

The US Food and Drug Administration is moving to speed drug development and review by launching real-time clinical trials.